New York's Coverage Gap: Where Cancer Treatment Access Actually Breaks Down
New York State Medicaid covers roughly 5 million New Yorkers who can't otherwise afford health care. On paper, that sounds like a strong safety net. Look closer at how cancer specifically is covered, and the net has holes in it that are easy to miss unless you're the one falling through.
New York runs a specific program, the Medicaid Cancer Treatment Program (MCTP), for people who aren't otherwise insured and need cancer treatment. To qualify, you need an income at or below 250% of the Federal Poverty Level. That's already a narrow window — a family earning just above that line gets no help from this program, regardless of what treatment costs. But the bigger issue is what MCTP actually covers: breast, cervical, colorectal, and prostate cancer. Four cancer types. If you're a low-income, uninsured New Yorker diagnosed with any other cancer, this particular safety net simply doesn't apply to you.
Zoom out from New York and the pattern holds nationally: Medicaid expansion is associated with real, measurable improvements — more patients starting treatment within 60 days of diagnosis for breast, cervical, and colon cancers, and better three-year survival for breast, cervical, and lung cancers. Cancer survivors in states that didn't expand Medicaid are more likely to report financial barriers to seeing a doctor and less likely to have a regular doctor at all. Coverage isn't just about whether a bill gets paid — it changes whether people get treated in time.
Put those two facts together and the shape of the problem gets clearer. New York has built real infrastructure for cancer patients who fall through the cracks of the insurance system — but only for four specific cancers, and only under a specific income threshold. Everyone else is left navigating a patchwork of hospital charity care, payment plans, and hoping a diagnosis doesn't also mean a financial one.
This is the kind of gap policy can actually close without waiting for a scientific breakthrough: expand which cancers MCTP covers, and the population it can reach immediately grows, using an infrastructure the state has already built and already knows works.